Cargando…

Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective

Detalles Bibliográficos
Autores principales:	Watermeyer, Tamlyn, Calia, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Edinburgh University Global Health Society 2019
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486120/ https://www.ncbi.nlm.nih.gov/pubmed/31073397 http://dx.doi.org/10.7189/jogh.09.010317

Ejemplares similares

Paradigm Shift Toward Digital Neuropsychology and High-Dimensional Neuropsychological Assessments: Review
por: Parsons, Thomas, et al.
Publicado: (2020)

Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s disease
por: Nakamura, Akinori, et al.
Publicado: (2018)

CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease
por: Paajanen, T., et al.
Publicado: (2013)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
por: Benejam, Bessy, et al.
Publicado: (2020)

REM Sleep Behavior Disorder and Prodromal Neurodegeneration – Where Are We Headed?
por: Postuma, Ronald B., et al.
Publicado: (2013)

The use of hippocampal grading as a biomarker for preclinical and prodromal Alzheimer's disease
por: Morrison, Cassandra, et al.
Publicado: (2023)

Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials
por: Hung, Anna, et al.
Publicado: (2020)

MRI-based Alzheimer’s disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer’s disease
por: Liu, Wanting, et al.
Publicado: (2021)

Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project
por: Wang, Huali, et al.
Publicado: (2019)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer’s Disease
por: Andrews, Murray, et al.
Publicado: (2021)

A journey with no roadmap—The need for validated criteria of the MS prodrome
por: Roman, Sharon
Publicado: (2022)

Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance
por: Zhang, TianHong, et al.
Publicado: (2015)

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview
por: Aisen, P.S., et al.
Publicado: (2020)

Capturing Cognitive Aging in Vivo: Application of a Neuropsychological Framework for Emerging Digital Tools
por: Hackett, Katherine, et al.
Publicado: (2022)

A new perspective on cutaneous leishmaniasis—Implications for global prevalence and burden of disease estimates
por: Bailey, Freddie, et al.
Publicado: (2017)

Mobile cognitive testing: opportunities for aging and neurodegeneration research in low- and middle-income countries
por: Muniz-Terrera, Graciela, et al.
Publicado: (2019)

Multidimensional Evaluation of Virtual Reality Paradigms in Clinical Neuropsychology: Application of the VR-Check Framework
por: Krohn, Stephan, et al.
Publicado: (2020)

Adolescent Parenting: Global Perspective, Local Action
por: Olszewski, Linda, et al.
Publicado: (2019)

COVID-19 vaccine inequality: A global perspective
por: Tatar, Moosa, et al.
Publicado: (2022)

The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
por: Bertens, Daniela, et al.
Publicado: (2017)

The economic burden of the post-COVID-19 condition: Underestimated long-term consequences of neuropsychological deficits
por: Voruz, Philippe, et al.
Publicado: (2023)

Inflammaging as a prodrome to Alzheimer's disease
por: Giunta, Brian, et al.
Publicado: (2008)

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
por: Meles, Sanne K., et al.
Publicado: (2021)

Tele-Neuropsychological Assessment of Alzheimer’s Disease
por: Carotenuto, Anna, et al.
Publicado: (2021)

Amyloid imaging in prodromal Alzheimer's disease
por: Ossenkoppele, Rik, et al.
Publicado: (2011)

Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia
por: Hackett, Katherine, et al.
Publicado: (2018)

Global Perspective and Ways to Combat Stigma Associated with COVID-19
por: Adiukwu, Frances, et al.
Publicado: (2020)

Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)
por: Walter, S., et al.
Publicado: (2020)

mHealth Assessment: Conceptualization of a Global Framework
por: Bradway, Meghan, et al.
Publicado: (2017)

Patient‐derived preclinical models to develop immunotherapies
por: Seoane, Joan
Publicado: (2023)

A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages
por: Abate, Giulia, et al.
Publicado: (2020)

Cognitive Trajectories in Preclinical and Prodromal Alzheimer’s Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach
por: Teipel, Stefan J, et al.
Publicado: (2023)

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
por: Rentz, Dorene M, et al.
Publicado: (2013)

Are We Sure We Fully Understand What an Infodemic Is? A Global Perspective on Infodemiological Problems
por: Rovetta, Alessandro, et al.
Publicado: (2022)

The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD): Experience from the First 3 Years
por: Walter, S., et al.
Publicado: (2020)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

Brainstem substructures and cognition in prodromal Alzheimer’s disease
por: Dutt, Shubir, et al.
Publicado: (2021)

Con: Can biomarkers be gold standards in Alzheimer's disease?
por: Rockwood, Kenneth
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_64b0a76n57dcjqak88g71gn57c